Lipoxen Plc (LIPX.L)
11.50GBp
11:30am EST
-0.50p (-4.17%)
12.00p
12.00p
12.00p
11.50p
44,573
66,319
29.00p
3.00p
LIPX.L
About
Overall
| Beta: | 3.12 |
| Market Cap (Mil.): | £18.53 |
| Shares Outstanding (Mil.): | 154.40 |
| Annual Dividend: | -- |
| Yield (%): | -- |
Financials
| LIPX.L | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 12.58 | 4.63 |
| EPS (TTM): | -4.03 | -- | -- |
| ROI: | -74.32 | 1.90 | 2.80 |
| ROE: | -74.32 | 3.14 | 4.09 |
UPDATE 1-Lipoxen says Baxter buys 4.8 pct stake in co
* Lipoxen raises 2.9 mln stg via discounted share issue
STOCKS NEWS EUROPE-UK small caps close 4.1 percent lower
The FTSE Small Cap index closes 4.1 percent lower, underperforming both the blue chips and the midcaps , which shed 2.1 percent and 3.3 percent, respectively.
STOCKS NEWS EUROPE-UK small caps fall 2.0 percent midday
The FTSE Small Cap index falls 2.0 percent in midday trade, in line with the midcaps , while the blue chips are off 1.0 percent.
STOCKS NEWS UK SMALL-Allergy Therapeutics soars on debt talk
STOCKS NEWS Reuters Results diary
STOCKS NEWS UK SMALL-VT Group up as FY beats forecasts
STOCKS NEWS Reuters Results diary
STOCKS NEWS EUROPE- Lipoxen up after malaria funding
Shares in vaccine delivery specialist Lipoxen rise 22 percent after the company announces it has received funding for its technology to be used in the development of a malaria vaccine as part of a project aided by scientists from the U.S. National Institute of Allergy and Infectious Diseases.
STOCKS NEWS UK SMALL-Lipoxen up after malaria funding
Europe [STXNEWS/EU] Real-time Equity News [E]
UPDATE 1-Lipoxen's Erepoxen data positive, '08 loss widens
* Shares rise as much as 21 pct in early trade (Adds details)
STOCKS NEWS EUROPE-FTSE Small caps up 1.6 pct at midday
The FTSE Small cap index gains 1.6 percent in mid-session trade, reflecting the positive mood in the wider market, which sees the FTSE 100 up 2.1 percent and the FTSE 250 2.7 percent higher.
STOCKS NEWS UK SMALL-Punch builds on gains as debt fears recede
STOCKS NEWS Reuters Results diary
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
